Clinical Chemistry

News Clinical Chemistry

• Frost & Sullivan determines a real and urgent need for novel cancer diagnostics tests

  The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on detection and diagnosis of cancer using mainly blood, faeces, urine tests or genetic tests. Testing methods are now gradually moving more

• Genzyme Announces Agreement to Sell Diagnostics Business to Sekisui Chemical Co.

  Genzyme Corporation announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme’s Diagnostic products business for $265 million in cash. Under the terms of the agreement, Sekisui will purchase substantially all of the assets of the busi more

• They shall not pass!

  The adaptive immune system can recognize and respond specifically to particular infectious agents. But the first line of defence against pathogens is the so-called innate immune system. This system reacts to invaders by initiating unspecific inflammatory responses which attract various types of spec more

Publications Clinical Chemistry

• Company Profile: Aviir, Inc.

  Aviir, Inc. is a venture-funded biotechnology company developing and commercializing laboratory tests to provide personalized information to physicians and patients, with the goal of preventing cardiovascular disease and metabolic syndromes. Leveraging advanced research, Aviir developed and launched more

• Action of hypoxia‐inducible factor in liver and kidney from mice with Pax8‐rtTA‐based deletion of von Hippel‐Lindau protein

  Abstract Aim Von Hippel‐Lindau protein (VHL) provides the degradation of hypoxia‐inducible factor (HIF). Tetracycline‐induced, Pax8‐rtTA‐based knockout of VHL (VHL‐KO) affects all renal tubules and periportal hepatocytes and leads to sustained upregulation of HIF. Here, we study the phenotype more

• Drug‐Induced Convulsions in Nonclinical Safety Studies: Implication for Clinical Development

  Abstract Preclinical Research The occurrence of convulsions in nonclinical safety studies during development of a new drug often complicates further development of the compound. Based on experiences with a previous development project at H. Lundbeck A/S, where convulsions were not more

Market studies Clinical Chemistry

• Abbott Laboratories Market Share Analysis

  Introduction GlobalData’s new report, “Abbott Laboratories Market Share Analysis” provides in-depth information on Abbott Laboratories’s market position in the different medical equipment markets it operates in. The report provides Abbott Laboratories market share information in 10 key market cate more

• In Vitro Diagnostics - India

  This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for in vitro diagnostics in India. The analysis provides essential market information for decision-makers including:   * Overall market for in vitro diagnostics in India * Market for more

• In Vitro Diagnostics - Germany

  This market research report offers an in-depth perspective on the actual market situation, trends and future outlook for in vitro diagnostics in Germany. The analysis provides essential market information for decision-makers including:   * Overall market for in vitro diagnostics in Germany * Market more

Websites Clinical Chemistry